Pay in 4 interest-free payments of $6.66 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Participants in the SURPASS trials reported weight loss of 15%-22% of their body weight, depending on dosage, compared to 10%-15% seen with GLP-1 in the STEP trials (Jastreboff et al., 2022)
We need more data on the long-term effects and other outcomes related to cardiovascular health, particularly in lower-risk individuals
Take home message Weight-loss injections are designed as additional tools for weight management interventions and shouldnt be considered lifelong medications
Compounded medications are prepared by licensed compounding pharmacies and have not undergone FDA review for safety, effectiveness, or quality as finished products
Staying hydrated is also important
US$ 26.27
US$ 26.59
US$ 24.75
